Cleared Traditional

K242089 - Vitrification Freeze Kit (RFD-0101) Vitrification Thaw Kit (RFD-0201, RFD-0202) (FDA 510(k) Clearance)

Class II Obstetrics & Gynecology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K242089 · Jiangsu Ruifuda Medical Device Co., Ltd. · Obstetrics & Gynecology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2025
Decision
267d
Days
Class 2
Risk

K242089 is an FDA 510(k) clearance for the Vitrification Freeze Kit (RFD-0101) Vitrification Thaw Kit (RFD-0201, RFD-0202). Classified as Media, Reproductive (product code MQL), Class II - Special Controls.

Submitted by Jiangsu Ruifuda Medical Device Co., Ltd. (Lianyungang, CN). The FDA issued a Cleared decision on April 10, 2025 after a review of 267 days - an extended review cycle.

This device falls under the Obstetrics & Gynecology FDA review panel, regulated under 21 CFR 884.6180 - the FDA obstetrics and gynecology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Obstetrics & Gynecology review framework, consistent with the majority of Class II 510(k) submissions.

View all Jiangsu Ruifuda Medical Device Co., Ltd. devices

Submission Details

510(k) Number K242089 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 17, 2024
Decision Date April 10, 2025
Days to Decision 267 days
Submission Type Traditional
Review Panel Obstetrics & Gynecology (OB)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
107d slower than avg
Panel avg: 160d · This submission: 267d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code MQL Media, Reproductive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 884.6180
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Obstetrics & Gynecology devices follow this clearance model.

Regulatory Consultant

Guangzhou Osmunda Medical Device Technical Service Co., Ltd.
Olivia Meng

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - MQL Media, Reproductive

All 258
Devices cleared under the same product code (MQL) and FDA review panel - the closest regulatory comparables to K242089.
Ultra-Fast Warm
K260248 · Kitazato Corporation · Apr 2026
CaseBio™ Culture w/HSA (CMH5)
K252672 · Casebioscience, Inc. · Feb 2026
Fast Warm - NX
K250445 · Fujifilm Irvine Scientific · Sep 2025
Dewin Reproductive Media (Dewin Gamete Buffer [with HSA and without HSA]
K251637 · Donnevie Medical Technology (Shanghai) Co. , Ltd. · Aug 2025
Ultra-Fast Vitri
K251305 · Kitazato Corporation · Aug 2025
FertiCult Flushing medium
K242640 · Fertipro NV · May 2025